Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
Amazon
AMZN
|
+$781M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$428M |
| 3 |
Meta Platforms (Facebook)
META
|
+$405M |
| 4 |
Uber
UBER
|
+$379M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$259M |
Top Sells
| 1 |
Tesla
TSLA
|
+$1.8B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$634M |
| 3 |
Apple
AAPL
|
+$537M |
| 4 |
Mastercard
MA
|
+$467M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$437M |
Sector Composition
| 1 | Technology | 16.3% |
| 2 | Financials | 12.05% |
| 3 | Consumer Discretionary | 11.61% |
| 4 | Healthcare | 11.53% |
| 5 | Communication Services | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXNX
901
DELISTED
Axonics, Inc. Common Stock
AXNX
| $18.4M | ﹤0.01% |
327,806
+229,711
| +234% | +$12.9M |
|
902
GitLab
GTLB
$8.32B
| $18.3M | ﹤0.01% |
+210,853
| New | +$18.3M |
|
903
iShares Core MSCI Europe ETF
IEUR
$6.93B
| $18.3M | ﹤0.01% |
315,404
-957,925
| -75% | -$55.7M |
|
904
Teleflex
TFX
$5.82B
| $18.3M | ﹤0.01% |
55,798
-2,213
| -4% | -$727K |
|
905
Banco Bradesco
BBD
$33.7B
| $18.3M | ﹤0.01% |
5,895,073
+4,246,214
| +258% | +$13.2M |
|
906
Cullen/Frost Bankers
CFR
$8.2B
| $18.3M | ﹤0.01% |
145,015
+29,069
| +25% | +$3.66M |
|
|
AFTR
907
DELISTED
AfterNext HealthTech Acquisition Corp.
AFTR
| $18.3M | ﹤0.01% |
+1,875,055
| New | +$18.3M |
|
908
Scotiabank
BNS
$79.7B
| $18.3M | ﹤0.01% |
254,714
-186,332
| -42% | -$13.4M |
|
909
Avantor
AVTR
$8.8B
| $18.3M | ﹤0.01% |
433,076
-104,363
| -19% | -$4.4M |
|
910
Packaging Corp of America
PKG
$19.5B
| $18.2M | ﹤0.01% |
133,362
-21,681
| -14% | -$2.95M |
|
911
Amicus Therapeutics
FOLD
$2.44B
| $18.1M | ﹤0.01% |
1,569,702
-1,304,692
| -45% | -$15.1M |
|
912
Pliant Therapeutics
PLRX
$102M
| $18.1M | ﹤0.01% |
1,337,126
+8,760
| +0.7% | +$118K |
|
913
Plains All American Pipeline
PAA
$12.1B
| $18M | ﹤0.01% |
1,931,085
+956,097
| +98% | +$8.93M |
|
|
VRN
914
DELISTED
Veren
VRN
| $18M | ﹤0.01% |
3,369,390
+2,587,914
| +331% | +$13.8M |
|
915
EyePoint Pharmaceuticals
EYPT
$928M
| $18M | ﹤0.01% |
1,469,213
+522,789
| +55% | +$6.4M |
|
916
Lam Research
LRCX
$146B
| $18M | ﹤0.01% |
249,870
-193,300
| -44% | -$13.9M |
|
917
Portland General Electric
POR
$4.62B
| $17.9M | ﹤0.01% |
338,341
+133,199
| +65% | +$7.05M |
|
918
Bilibili
BILI
$9.95B
| $17.9M | ﹤0.01% |
384,985
+279,921
| +266% | +$13M |
|
919
Regenxbio
RGNX
$473M
| $17.8M | ﹤0.01% |
545,717
+389,339
| +249% | +$12.7M |
|
920
GameStop
GME
$11B
| $17.8M | ﹤0.01% |
+480,340
| New | +$17.8M |
|
921
Sabre
SABR
$730M
| $17.8M | ﹤0.01% |
2,073,803
+1,337,488
| +182% | +$11.5M |
|
922
Amdocs
DOX
$9.29B
| $17.7M | ﹤0.01% |
236,641
-56,387
| -19% | -$4.22M |
|
|
SNCE
923
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $17.7M | ﹤0.01% |
71,174
+49,265
| +225% | +$12.3M |
|
|
ZNGA
924
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $17.7M | ﹤0.01% |
2,763,891
-611,687
| -18% | -$3.91M |
|
925
Macerich
MAC
$4.6B
| $17.6M | ﹤0.01% |
1,018,771
+75,410
| +8% | +$1.3M |
|